title: Antioxidant effects of maslinic acid in livers, hearts and kidneys of streptozotocin-induced diabetic rats: effects on kidney function.
abstract: Studies indicate that hyperglycemia-induced oxidative stress triggers the development of microvascular and macrovascular complications in diabetes. Accordingly, we hypothesized that maslinic acid (MA) prevents these complications due to its antioxidant properties. We, therefore, investigated the effects of 5-week MA treatment of streptozotocin (STZ)-induced diabetic rats on anti-oxidative status of cardiac, hepatic and renal tissues as well as on kidney function. Proximal tubular effects of MA were studied in anesthetized rats challenged with hypotonic saline after a 3.5 h equilibration for 4 h of 1 h control, 1.5 h treatment and 1.5 h recovery periods using lithium clearance. MA was added to the infusate during the treatment period. Oral glucose tolerance responses to MA were monitored in rats given a glucose load after an 18 h fast. Compared with untreated diabetic rats, MA-treated diabetic animals exhibited significantly low malondialdehyde (MDA, a marker of lipid peroxidation) and increased the activity of antioxidant enzymes; superoxide dismutase and glutathione peroxidase in hepatic, cardiac and renal tissues. The expressions of gastrocnemius muscle GLUT4 and kidney GLUT1 and GLUT2 were assessed to elucidate the mechanism of the hypoglycemic effects of MA. MA-treatment diminished the expression of GLUT1 and GLUT2 in diabetic kidney and reduced glycemia values of diabetic rats. MA administration increased urinary Na+ outputs and additionally the FENa indicating that at least part of the overall reduction in Na+ reabsorption occurred in the proximal tubules. These results suggest antioxidant effects of MA can ameliorate oxidative stress and improve kidney function in diabetes mellitus.
authors.affiliation: School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal , Durban , South Africa and.
authors.forename: Blessing N
authors.initials: BN
authors.lastname: Mkhwanazi
authors.forename: Metse R
authors.initials: MR
authors.lastname: Serumula
authors.forename: Rene B
authors.initials: RB
authors.lastname: Myburg
authors.forename: Fanie R
authors.initials: FR
authors.lastname: Van Heerden
authors.forename: Cephas T
authors.initials: CT
authors.lastname: Musabayane
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy / Q000503:physiopathology*; D004326:Drinking / Q000187:drug effects; D051246:Glucose Transport Proteins, Facilitative / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006321:Heart / Q000187:drug effects*; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007687:Kidney Tubules, Proximal / Q000187:drug effects* / Q000378:metabolism; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008315:Malondialdehyde / Q000097:blood; D009206:Myocardium / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar; D012964:Sodium / Q000378:metabolism; D014315:Triterpenes / Q000494:pharmacology*; D014882:Water-Electrolyte Balance / Q000187:drug effects; D009828:Oleanolic Acid / Q000031:analogs & derivatives
chemical_list: D000975:Antioxidants; D001786:Blood Glucose; D051246:Glucose Transport Proteins, Facilitative; D006003:Glycogen; D007328:Insulin; D008315:Malondialdehyde; D012964:Sodium; D014315:Triterpenes; C412811:maslinic acid; D009828:Oleanolic Acid